For laboratory research only. Not for human consumption.Our comparison method ↗
deals on
peptidesSaved 0
Studio-style Deals on Peptides product visual for KPV

Vial comparison

KPV prices

Compare KPV listings by strength, selection and supplier. Inspect the original source behind each price.

39suppliers represented
49source-linked listings
6strengths available
Other formatsKPV Atomized Solution Kit Capsule

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 5 mg5 suppliers · Pack counts: 1
  • 10 mg33 suppliers · Pack counts: 1, 2, 3, 10
  • 12 mg1 supplier · Pack counts: 1
  • 16 mg1 supplier · Pack counts: 1
  • 20 mg1 supplier · Pack counts: 1
  • 30 mg1 supplier · Pack counts: 1

Reported quantities in this family: 1, 2, 3, 10. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. 1 listing in this family have incomplete quantity details and receive no inferred per-mg price.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
5 mg1 vial$28.00$5.605Compare
10 mg1 vial$26.51$2.6531Compare
12 mg1 vial$28.04$2.341Compare
16 mg1 vial$43.75$2.731Compare
20 mg1 vial$62.10$3.111Compare

Suppliers with KPV listings

39 profiles
View 33 more supplier profiles

Sources and comparison limits

4 listings from direct supplier captures and 45 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more vial listings

BPC-157GHK-CuMOTS-cIpamorelinNAD+Tesamorelin

Browse all products

FROM PEPTIDES CALCULATOR

About KPV

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

KPV is the tripeptide lysine-proline-valine, the last three residues of alpha-melanocyte-stimulating hormone and therefore also residues 11-13 of ACTH, which begins with the same 13-amino-acid sequence. Reviews from the Munster dermatology group describe it as the part of alpha-MSH that keeps the hormone's anti-inflammatory activity without its pigment-stimulating effect, and mechanistic work suggests it acts inside cells, entering through the PepT1 peptide transporter and damping NF-kB signalling rather than binding melanocortin receptors; it also inhibits Staphylococcus aureus and Candida albicans in culture. Every efficacy result comes from cell lines or from mouse and rat models of colitis, peritonitis, skin and corneal injury, including two 2008 mouse colitis studies, and the FDA's July 2026 review for compounding found no clinical study, no human exposure data and no pharmacokinetic or toxicity study in any species. KPV is sold as a research chemical and promoted by compounding and telehealth outlets as injections, capsules, creams and nasal sprays; FDA reviewers proposed against listing it for 503A compounding, the advisory committee nevertheless voted 8 to 6 to recommend it, and rulemaking had not concluded when this dossier was written.

Formula
C16 H30 N4 O4
Molar mass
342.4 g/mol
CAS number
67727-97-3
Amino acids
3

Research evidence described in the source

Animal

Multiple mouse colitis models

KPV reduced selected inflammatory and histologic measures in preclinical intestinal models.

In vitro

Human epithelial and immune cells

Nanomolar KPV was studied in cytokine-stimulated cell systems with PepT1-dependent uptake.

Review

No established clinical regimen

Published evidence does not establish injectable efficacy or long-term safety in humans.

Limitations noted in the source

  • Mouse colitis outcomes do not establish treatment effects in human inflammatory bowel disease.
  • Oral PepT1-targeted research is not equivalent to an injectable preset.
  • A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
  • Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.